Biomarkers of inflammation and risk of cardiovascular events in anticoagulated patients with atrial fibrillation

Interleukin-6 and C-reactive protein and risk for death and cardiovascular events in patients with atrial fibrillation

(2015) Julia Aulin et al.   AMERICAN HEART JOURNAL

Growth Differentiation Factor 15, a Marker of Oxidative Stress and Inflammation, for Risk Assessment in Patients With Atrial Fibrillation

(2014) Lars Wallentin et al.   CIRCULATION

Importance of persistent elevation of cardiac biomarkers in atrial fibrillation: a RE-LY substudy

(2014) Ziad Hijazi et al.   HEART

High-Sensitivity Troponin I for Risk Assessment in Patients With Atrial Fibrillation

(2013) Ziad Hijazi et al.   CIRCULATION

Biomarkers in atrial fibrillation: a clinical review

(2013) Z. Hijazi et al.   EUROPEAN HEART JOURNAL

N-Terminal Pro–B-Type Natriuretic Peptide for Risk Assessment in Patients With Atrial Fibrillation

(2013) Ziad Hijazi et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

High-Sensitivity C-Reactive Protein and Cardiovascular Disease

(2013) Omair Yousuf et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Cardiac Biomarkers Are Associated With an Increased Risk of Stroke and Death in Patients With Atrial Fibrillation

(2012) Ziad Hijazi et al.   CIRCULATION

Efficacy of apixaban when compared with warfarin in relation to renal function in patients with atrial fibrillation: insights from the ARISTOTLE trial

(2012) Stefan H. Hohnloser et al.   EUROPEAN HEART JOURNAL

Inflammation in Atrial Fibrillation

(2012) Yutao Guo et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

High sensitivity cardiac troponin T and interleukin-6 predict adverse cardiovascular events and mortality in anticoagulated patients with atrial fibrillation

(2012) V. ROLDÁN et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Usefulness of High-Sensitivity C-Reactive Protein to Predict Mortality in Patients With Atrial Fibrillation (from the Atherosclerosis Risk In Communities [ARIC] Study)

(2011) José Hermida et al.   AMERICAN JOURNAL OF CARDIOLOGY

Apixaban versus Warfarin in Patients with Atrial Fibrillation

(2011) Christopher B. Granger et al.   NEW ENGLAND JOURNAL OF MEDICINE

Apixaban for Reduction In Stroke and Other ThromboemboLic Events in Atrial Fibrillation (ARISTOTLE) trial: Design and rationale

(2010) Renato D. Lopes et al.   AMERICAN HEART JOURNAL

Bleeding events are associated with an increase in markers of inflammation in acute coronary syndromes: an ACUITY trial substudy

(2010) Charles L. Campbell et al.   JOURNAL OF THROMBOSIS AND THROMBOLYSIS

C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis

(2009)   LANCET

Immuno-inflammatory predictors of stroke at follow-up in patients with chronic non-valvular atrial fibrillation (NVAF)

(2008) Antonio Pinto et al.   CLINICAL SCIENCE